Discontinuation report EMCYT

Last updated on 2019-11-12 History
Report ID 98547
Drug Identification Number 02063794
Brand name EMCYT
Common or Proper name EMCYT
Company Name PFIZER CANADA ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) ESTRAMUSTINE PHOSPHATE SODIUM
Strength(s) 140MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 100's
ATC code L01XX
ATC description OTHER ANTINEOPLASTIC AGENTS
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2019-11-07
Remaining supply date 2020-02-28
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply Inventory will be available for distribution until February 28, 2020
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2019-11-12 English Compare
v2 2019-11-12 French Compare

Showing 1 to 2 of 2